Selected Publications

1. Choi JY*, Lee H*, Kwon EJ*, Kong HJ, Kwon OS, Cha HJ†, TGF-β promotes YAP dependent AXL induction in mesenchymal lung cancer cells, Molecular Oncology, 15(2):679-696 (2021)

2. Kwon OS, Kwon EJ, Kong HJ, Choi JY, Kim YJ, Lee EW, Kim W, Lee H†, Cha HJ†, Systematic identification of a nuclear receptor-enriched predictive signature for erastin-induced ferroptosis. Redox Biology, 37:101719 (2020)

3. Kwon OS*, Lee H*, Kong HJ, Park JE, Lee W, Kang S, Kim M, Kim W†, Cha HJ†, Connectivity Map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer. Oncogene, 39(23):4567-4580 (2020)

4. Kwon OS, Kim W, Cha HJ, Lee H†, In silico drug repositioning: from large-scale transcriptome data to therapeutics. Archives of Pharmacal Research, 42(10):879-889 (2019)

5. Hong SK*, Lee H*, Kwon OS*, …, Kim W†, Cha HJ†, Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer, Molecular Cancer. 17(1):175 (2018)

6. Lee H, Kang S, Kim W†, Drug Repositioning for cancer therapy based on large-scale drug-induced transcriptional signature. PLoS ONE, 11(3):e0150460, (2016)